References
- Passeron T, Picardo M. Melasma, a photoaging disorder. Pigment Cell Melanoma Res. 2018;31(4):461–65. doi: 10.1111/pcmr.12684.
- Lee BW, Schwartz RA, Janniger CGIDV. Melasma. Ital J Dermatol Venereol. 2017;152(1):36–45. doi: 10.23736/S0392-0488.16.05425-0.
- Kwon SH, Na JI, Choi JY, Park KC. Melasma: updates and perspectives. Exp Dermatol. 2019;28(6):704–08. doi:10.1111/exd.13844.
- Kwon SH, Hwang YJ, Lee SK, Park KC. Heterogeneous pathology of melasma and its clinical implications. Int J Mol Sci. 2016;17(6):824. doi:10.3390/ijms17060824.
- Austin E, Nguyen JK, Jagdeo J. Topical treatments for melasma: a systematic review of randomized controlled trials. J Drugs Dermatol. 2019;18(11):S1545961619P1156X.
- Kagha K, Fabi S, Goldman MP. Melasma’s impact on quality of life. J Drugs Dermatol. 2020;19(2):184–87. doi: 10.36849/JDD.2020.4663.
- Rajanala S, Maymone MBC, NA V. Melasma pathogenesis: a review of the latest research, pathological findings, and investigational therapies. Dermatol Online J. 2019;25(10):13030/qt47b7r28c. doi: 10.5070/D32510045810.
- Bagherani N, Gianfaldoni S, Smoller B. An overview on melasma. J Pigment Disord. 2015;2(10):1000216. doi: 10.4172/2376-0427.1000216.
- Vachiramon V, Suchonwanit P, Thadanipon K. Melasma in men. J Cosmet Dermatol. 2012 Jun;11(2):151–57. doi:10.1111/j.1473-2165.2012.00613.x.
- Handel AC, Miot LD, Miot HA. Melasma: a clinical and epidemiological review. An Bras Dermatol. 2014 Sep-Oct;89(5):771–82. doi:10.1590/abd1806-4841.20143063.
- Gauthier Y, Cario M, Pain C, Lepreux S, Benzekri L, Taieb A. Oestrogen associated with ultraviolet B irradiation recapitulates the specific melanosome distribution observed in caucasoid melasma. Br J Dermatol. 2019 Apr;180(4):951–53. doi:10.1111/bjd.17453.
- Kheradmand M, Afshari M, Damiani G, Abediankenari S, Moosazadeh M. Melasma and thyroid disorders: a systematic review and meta-analysis. Int J Dermatol. 2019;58(11):1231–38. doi:10.1111/ijd.14497.
- Kruglova LS, Ikonnikova EV. Hyperpigmentation of the skin: modern views on etiology and pathogenesis (part 1). Russ J Skin Venereal Dis. 2017;20(3):178–83. doi: 10.18821/1560-9588-2017-20-3-178-183.
- Fedotov VP. Skin pigmentation disorders (dyschromia). Dermatovenereol Cosmetol Sexopathol. 2014;1-4:114–30.
- VV G, AA S, SA M, Flaks GA, Il’ina IV. Increasing the effectiveness of melasma therapy. Russ J Skin Venereal Dis. 2017;20(2):85. doi: 10.17816/dv37248.
- Passeron T. Melasma pathogenesis and influencing factors - an overview of the latest research. J Eur Acad Dermatol Venereol. 2013;27(1):5–6. doi:10.1111/jdv.12049.
- Li JY, Geddes ER, Robinson DM, Friedman PM. A review of melasma treatment focusing on laser and light devices. Semin Cutan Med Surg. 2016;35(4):223–32. doi:10.12788/j.sder.2016.060.
- Ikonnikova EV, Korchazhkina NB, Stenko AG. Laser technologies in the correction of non-tumor melanin hyperpigmentation of the skin. Russ J Physui Balneo Rehab. 2018;17(1):19–24. doi: 10.18821/1681-3456-2018-17-1-19-24.
- Tamega Ade A, Miot HA, Moço NP, Silva MG, Marques MEA, Miot, LDB. Gene and protein expression of oestrogen-β and progesterone receptors in facial melasma and adjacent healthy skin in women. Int J Cosmet Sci. 2015;37(2):222–28. doi:10.1111/ics.12186.
- McKesey J, Tovar-Garza A, Pandya AG. Melasma treatment: an evidence-based review. Am J Clin Dermatol. 2020;21(2):173–225. doi:10.1007/s40257-019-00488-w.
- Yunusova EI, Yusupova LA, Zalyaleeva SA. Melanin dyschromias of the skin. Exp Clin Dermatocosmetol. 2012;6:25–27.
- Achar A, Rathi SK. Melasma: a clinico-epidemiological study of 312 cases. Indian J Dermatol. 2011;56(4):380–82. doi: 10.4103/0019-5154.84722.
- Hexsel D, Lacerda DA, Cavalcante AS, Filho CASM, Kalil CLPV, Ayres EL, Azulay-Abulafia L, Weber MB, Serra MS, Lopes NFP, et al. Epidemiology of melasma in Brazilian patients: a multicenter study. Int J Dermatol. 2014;53(4):440–44. doi:10.1111/j.1365-4632.2012.05748.x.
- Uyanikoglu H, Aksoy M. Quality of life in patients with melasma in Turkish women. Dermatol Reports. 2017;9(2):7340. doi:10.4081/dr.2017.7340.
- Friedman EB, Scolyer RA, Thompson JF. Management of pigmented skin lesions during pregnancy. Aust J Gen Pract. 2019;48(9):621–24. doi:10.31128/AJGP-04-19-48952.
- Wu IB, Lambert C, Lotti TM, Hercogová J, Sintim-Damoa A, Schwartz RA. Melasma. G Ital Dermatol Venereol. 2012;147(4):413–18.
- Ovsyannikova G. Pregnancy: prevention of aesthetic problems. Kosmetik Int. 2013;5:154–58.
- Monakhov SA. Pregnancy stigmata. Russ J Skin Venereal Dis. 2012;15(5):60.
- KhM K, ShV K. A view of the problem of pregnancy-specific skin dermatoses (part one). Clin Dermatol Venereol. 2014;12(6):82–86. doi: 10.17116/klinderma2014682-86.
- Zhang Y, Zheng X, Chen Z, Lu L. Laser and laser compound therapy for melasma: a meta-analysis. J Dermatolog Treat. 2020;31(1):77–83. doi:10.1080/09546634.2019.1577544.
- Shelemba EI. Optimization of the treatment method of patients with facial hypermelanoses under different skin phototypes. Dermatovenereol Cosmetol Sexopathol. 2018;1-4:63–69.